Atlas Trials

Nivolumab Combined With SOX Used in the Perioperative Treatment

Clinical trial NCT05739045 · UNKNOWN

Trial details

NCT number
NCT05739045
Sponsor
Xiangdong Cheng
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Immune SuppressionGastric Cancer
Start date
2022-11-03
Primary completion
2024-12-31
Enrollment
46

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.